Integra Therapeutics

Integra Therapeutics is a biotechnology company headquartered in Spain, dedicated to developing next-generation gene editing to treat genetic diseases, aiming to enhance the efficiency and safety of advanced therapies. At Integra Therapeutics, we combine the precision of CRISPR systems with the gene transfer efficiency of viral integrases and transposases. By utilizing natural evolution to introduce large DNA segments into genomes, along with the precision of sequence-specific DNA binding proteins, we achieve unprecedented efficiency in programmable gene delivery.